Skip to main content
. 2024 Nov 29;103(48):e40697. doi: 10.1097/MD.0000000000040697

Table 4.

Multivariate cox-proportional hazard analysis of 3-yr events, based on beta-blocker prescription at discharge (N = 12,200).

Events With beta-blockers (N = 10,251) Without beat-blockers (N = 1949) Hazard ratio* (95% CI) P value
No. of patients with events (rate per 100 patient-year)
Cardiac death 483 (1.8) 162 (3.3) 0.78 (0.64–0.94) .010
All-cause death 787 (2.9) 249 (5.0) 0.79 (0.68–0.93) .003
MI 334 (1.2) 63 (1.3) 1.06 (0.79–1.41) .712
Revascularization 891 (3.4) 155 (3.3) 0.99 (0.83–1.19) .920
Heart failure 358 (1.3) 102 (2.1) 0.82 (0.65–1.03) .089
MACE 1620 (6.4) 388 (8.6) 0.87 (0.77–0.97) .017
Stroke 213 (0.8) 40 (0.8) 1.05 (0.73–1.50) .800
MACCE 1786 (7.1) 418 (9.3) 0.89 (0.79–0.99) .035
NCD 305 (1.1) 87 (1.8) 0.83 (0.64–1.07) .151
MACE with NCD 1883 (7.4) 458 (10.1) 0.87 (0.78–0.97) .010

Abbreviations: CI = confidence interval, MACCE = major adverse cardiocerebral event, MACE = major adverse cardiac event, MI = myocardial infarction, NCD = noncardiac death.

*

Adjusted for age, sex, body mass index, hypertension, diabetes mellitus, prior angina, prior MI, prior heart failure, current smoker status, Killip class, estimated glomerular filtration rate, left ventricular ejection fraction, type of myocardial infarction, coronary reperfusion, and medications at discharge (aspirin, P2Y12 inhibitors, inhibitors of the renin-angiotensin system, and statins).

Unadjusted event rate.

Re-hospitalization due to heart failure.